Peripheral Arterial Disease (PAD) Therapeutics - Global Strategic Business Report

The global market for Peripheral Arterial Disease (PAD) Therapeutics is estimated at US$4.8 Billion in 2023 and is projected to reach US$7.8 Billion by 2030, growing at a CAGR of 7.0% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Significant growth drivers in the PAD therapeutics market include technological advancements in diagnostic imaging, like duplex ultrasound and magnetic resonance angiography, which enhance early and accurate disease detection. The rising prevalence of lifestyle diseases such as diabetes and obesity also escalates PAD cases, boosting demand for effective treatments. Increased public and medical awareness through educational campaigns and screening programs, along with innovations in drug development and personalized medicine, are pushing the boundaries of traditional PAD treatment approaches. Moreover, the trend towards minimally invasive procedures, expansion of drug indications originally developed for other cardiovascular conditions, and evolving healthcare policies and reimbursement scenarios are reshaping treatment paradigms, fostering greater adoption of novel therapeutics in the management of PAD.

Key Insights:

Market Growth: Understand the significant growth trajectory of the Peripheral Stents segment, which is expected to reach US$1.8 Billion by 2030 with a CAGR of a 6.8%. The Peripheral Angioplasty Balloons segment is also set to grow at 6.3% CAGR over the analysis period.
Regional Analysis: Gain insights into the U.S. market, estimated at $1.3 Billion in 2023, and China, forecasted to grow at an impressive 6.6% CAGR to reach $1.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

Detailed Market Analysis: Access a thorough analysis of the Global Peripheral Arterial Disease (PAD) Therapeutics Market, covering all major geographic regions and market segments.
Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Peripheral Arterial Disease (PAD) Therapeutics Market.
Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

How is the Global Peripheral Arterial Disease (PAD) Therapeutics Market expected to evolve by 2030?
What are the main drivers and restraints affecting the market?
Which market segments will grow the most over the forecast period?
How will market shares for different regions and segments change by 2030?
Who are the leading players in the market, and what are their prospects?

Report Features:

Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
Company Profiles: Coverage of major players such as AstraZeneca Plc., Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb Company, and more.
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 32 Featured):

AstraZeneca Plc.
Bayer HealthCare Pharmaceuticals
Bristol-Myers Squibb Company
Merck & Co., Inc.
Proteon Therapeutics, Inc.
Sanofi S.A.
Symic Bio, Inc.
TheraVasc, Inc.

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
Peripheral Arterial Disease (PAD) Therapeutics - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Global Economic Update

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Rising Prevalence of PAD Throws the Spotlight on Therapeutic Needs
Increasing Aging Population Expands Addressable Market Opportunity
Advancements in Drug Delivery Systems Drive Adoption of PAD Therapeutics
Innovations in Minimally Invasive Procedures Spur Market Growth
Development of Novel Antiplatelet Agents Generates Demand for Advanced Therapies
Increased Focus on Personalized Medicine Drives Adoption of Targeted Treatments
Technological Innovations in Imaging and Diagnostic Tools Expand Market Potential
Rising Healthcare Expenditure and Access to Treatment Propel Market Expansion
Emergence of Combination Therapies Generates New Opportunities for PAD Treatment
Patent Expirations and Generic Competition Affect Market Dynamics
Adoption of Digital Health Technologies Drives Market Adoption
Growing Importance of Vascular Health Awareness Campaigns Strengthens Market Demand
Innovations in Stem Cell and Gene Therapies Propel Growth in PAD Therapeutics
Expanding Applications of PAD Therapeutics in Other Vascular Diseases Drive Market Growth
Advancements in Biomarker Discovery and Diagnostics Sustain Market Growth
Integration with Telemedicine and Remote Monitoring Generates Market Opportunities
Technological Convergence with Other Therapeutic Modalities Expands Market Potential
Challenges in Clinical Trials and Regulatory Hurdles Impact the Market

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for Peripheral Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 2: World Historic Review for Peripheral Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 3: World 16-Year Perspective for Peripheral Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 4: World Recent Past, Current & Future Analysis for Peripheral Angioplasty Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 5: World Historic Review for Peripheral Angioplasty Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 6: World 16-Year Perspective for Peripheral Angioplasty Balloons by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 7: World Recent Past, Current & Future Analysis for Plaque Modification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 8: World Historic Review for Plaque Modification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 9: World 16-Year Perspective for Plaque Modification Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 10: World Recent Past, Current & Future Analysis for Inferior Vena Cava (IVC) Filters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 11: World Historic Review for Inferior Vena Cava (IVC) Filters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 12: World 16-Year Perspective for Inferior Vena Cava (IVC) Filters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 13: World Recent Past, Current & Future Analysis for Hemodynamic Flow Alteration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 14: World Historic Review for Hemodynamic Flow Alteration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 15: World 16-Year Perspective for Hemodynamic Flow Alteration Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 16: World Recent Past, Current & Future Analysis for Peripheral Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 17: World Historic Review for Peripheral Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 18: World 16-Year Perspective for Peripheral Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 19: World Recent Past, Current & Future Analysis for Peripheral Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 20: World Historic Review for Peripheral Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 21: World 16-Year Perspective for Peripheral Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 22: World Peripheral Arterial Disease (PAD) Therapeutics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
Table 23: World Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 24: World Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 25: World 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

UNITED STATES

Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
Table 26: USA Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 27: USA Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 28: USA 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030

CANADA

Table 29: Canada Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 30: Canada Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 31: Canada 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030

JAPAN

Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
Table 32: Japan Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 33: Japan Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 34: Japan 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030

CHINA

Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
Table 35: China Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 36: China Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 37: China 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030

EUROPE

Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
Table 38: Europe Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 39: Europe Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 40: Europe 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030
Table 41: Europe Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 42: Europe Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 43: Europe 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030

FRANCE

Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
Table 44: France Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 45: France Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 46: France 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030

GERMANY

Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
Table 47: Germany Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 48: Germany Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 49: Germany 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030

ITALY

Table 50: Italy Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 51: Italy Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 52: Italy 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030

UNITED KINGDOM

Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
Table 53: UK Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 54: UK Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 55: UK 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030

REST OF EUROPE

Table 56: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 57: Rest of Europe Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 58: Rest of Europe 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030

ASIA-PACIFIC

Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
Table 59: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 60: Asia-Pacific Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 61: Asia-Pacific 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030

REST OF WORLD

Table 62: Rest of World Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Table 63: Rest of World Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 64: Rest of World 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030

IV. COMPETITION

Companies Mentioned

AstraZeneca Plc.
Bayer HealthCare Pharmaceuticals
Bristol-Myers Squibb Company
Merck & Co., Inc.
Proteon Therapeutics, Inc.
Sanofi S.A.
Symic Bio, Inc.
TheraVasc, Inc.

Table Information

Report Attribute	Details
No. of Pages	188
Published	November 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 4.8 Billion
Forecasted Market Value ( USD ) by 2030	$ 7.8 Billion
Compound Annual Growth Rate	7.0%
Regions Covered	Global
No. of Companies Mentioned	8

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5328EUR$5,450USD£4,450GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€10123EUR$10,355USD£8,456GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€15984EUR$16,350USD£13,351GBP

Key Insights:

Why You Should Buy This Report:

Key Questions Answered:

Report Features:

Select Competitors (Total 32 Featured):

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Peripheral Artery Disease Market Report by Type Filters, End User, and Region 2024-2032

Peripheral Artery Disease Market Size, Share & Trends Analysis Report By Product Type (Drugs, and Devices), By End User (Hospitals, and Specialty Clinics), By Regional Outlook and Forecast, 2024 - 2031

Peripheral Artery Disease Market By Product Type, By End User: Global Opportunity Analysis and Industry Forecast, 2024-2035

Peripheral Arterial Disease Therapeutics Market by Treatment Type, Indication Stage, End-Users - Global Forecast 2025-2030

Peripheral Arterial Disease Global Market Report 2024